Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$277.25 - $366.29 $316,342 - $417,936
-1,141 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$300.63 - $371.35 $184,586 - $228,008
-614 Reduced 34.99%
1,141 $410,000
Q3 2021

Nov 12, 2021

SELL
$310.19 - $376.2 $147,340 - $178,695
-475 Reduced 21.3%
1,755 $571,000
Q2 2021

Aug 13, 2021

SELL
$262.71 - $351.17 $48,601 - $64,966
-185 Reduced 7.66%
2,230 $696,000
Q1 2021

May 14, 2021

BUY
$285.92 - $355.13 $370,552 - $460,248
1,296 Added 115.82%
2,415 $770,000
Q4 2020

Feb 12, 2021

BUY
$251.88 - $324.2 $281,853 - $362,779
1,119 New
1,119 $363,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Fort, L.P. Portfolio

Follow Fort, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.